E-Z-EM to expand Canadian subsidiary
Due to growth in its pharmaceutical and contrast manufacturing business, contrast agent developer E-Z-EM plans to expand the facilities of its Canadian subsidiary, E-Z-EM Canada. The Westbury, NY, company will rent an additional 46,000 square feet
Due to growth in its pharmaceutical and contrast manufacturing business, contrast agent developer E-Z-EM plans to expand the facilities of its Canadian subsidiary, E-Z-EM Canada. The Westbury, NY, company will rent an additional 46,000 square feet adjacent to E-Z-EM Canadas existing 70,000-square-foot facility in Montreal. E-Z-EM Canada will occupy the new site in March, and has the option to lease additional space or buy the facility in the future. E-Z-EM Canada attributed its need for a larger site to increased sales of its major product lines in the past two years, according to Pierre-Andre Ouimet, president.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
